Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson

Last Updated: November 27, 2022

Gentamicin sulfate - Generic Drug Details

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

What are the generic sources for gentamicin sulfate and what is the scope of patent protection?

Gentamicin sulfate is the generic ingredient in twelve branded drugs marketed by Schering, Pharmafair, Alpharma Us Pharms, Cosette, Fougera Pharms Inc, Padagis Us, Pharmaderm, Taro, King Pharms, Bristol, Intl Medication, Abbott, Fresenius Kabi Usa, Hikma, Hospira, Kalapharm, Pharm Spec, Solopak, Teva Parenteral, Watson Labs, Wyeth Ayerst, B Braun, Baxter Hlthcare, Pharmacia And Upjohn, Novartis, Akorn, Fera Pharms Llc, Pai Holdings Pharm, Allergan, Alcon Pharms Ltd, Bausch And Lomb, Paco, and Sandoz Inc, and is included in sixty NDAs. Additional information is available in the individual branded drug profile pages.

There are fourteen drug master file entries for gentamicin sulfate. Twenty-five suppliers are listed for this compound.

Summary for gentamicin sulfate
US Patents:0
Drug Master File Entries: 14
Finished Product Suppliers / Packagers: 25
Clinical Trials: 13
Formulation / Manufacturing:see details
What excipients (inactive ingredients) are in gentamicin sulfate?gentamicin sulfate excipients list
DailyMed Link:gentamicin sulfate at DailyMed
Drug Sales Revenue Trends for gentamicin sulfate

See drug sales revenues for gentamicin sulfate

Recent Clinical Trials for gentamicin sulfate

Identify potential brand extensions & 505(b)(2) entrants

Oslo University HospitalPhase 1/Phase 2
Kaiser PermanentePhase 2
University of California, San DiegoPhase 2

See all gentamicin sulfate clinical trials

Pharmacology for gentamicin sulfate

US Patents and Regulatory Information for gentamicin sulfate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare GENTAMICIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER gentamicin sulfate INJECTABLE;INJECTION 062373-001 Sep 7, 1982 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Akorn GENTAK gentamicin sulfate SOLUTION/DROPS;OPHTHALMIC 064163-001 Oct 12, 2001 AT RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Fougera Pharms Inc GENTAMICIN SULFATE gentamicin sulfate OINTMENT;TOPICAL 062533-001 Oct 5, 1984 AT RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.